Juntas adelante: a Peer-Coaching intervention to promote chemoprophylaxis for HIV prevention among latina transgender women in the washington DC metropolitan area.
NCT ID NCT07808541
First seen Sep 09, 2026 · Last updated Sep 09, 2026
Summary
The goal of this clinical trial is to evaluate the impact of the Juntas Adelante intervention on awareness and use of chemoprophylaxis for HIV prevention (Pre- and Post-Exposure prophylaxis, or PrEP and PEP) among Latina Transgender Women in the Washington DC Metropolitan Area. Secondary outcomes included awareness and use of Doxy-PEP (i.e., Doxycycline for prevention of Sexually Transmitted Infections - STI), and awareness of Undetectable = Untransmittable (U=U). The main questions are: 1. Is the Juntas Adelante intervention acceptable and feasible to implement with this population? 2. Is participating in the Juntas Adelante intervention associated with increased awareness and use of PrEP and PEP? All participants in the study will view 5 online short videos on HIV and STI prevention and will receive up to two virtual coaching sessions with a peer coach. They will also complete a brief survey after viewing each video (5 total) and three longer surveys/interviews over the course of 3 months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
39 people
The number who actually took part.
- Started
-
Oct 2024
- Finished
-
Aug 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male sex assigned at birth, currently identifying as a woman, transgender woman, transgender, or transsexual, irrespective of gender transition stage; * Identifying as Latina, regardless of country of birth; * Being 18 years old or older; * Living in the DC metropolitan area; * Self-reporting HIV negative status at study enrollment * Reporting having receptive anal and/or neovaginal sex with at least one cisgender man or transgender woman in the previous 12 months; * Not currently using PrEP or report less than 3 months of use; * Must have access to a cellphone with internet capabilities, * Not planning to move from the DC metropolitan area in the next 12 months Exclusion Criteria: \- Not meeting all of the inclusion criteria.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Prevention of HIV infection are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The George Washington University
Washington D.C., District of Columbia, 20037, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.